Gynecologic Oncology: From Molecular Mechanisms to Personalized Treatment
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 28
Special Issue Editors
Interests: gynecology; oncology; obstetrics; breast; uterus; endometriosis; fibroid; ovarian
Interests: surgery; transplantation; surgical oncology; oncology; experimental surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gynecologic cancers pose significant challenges to women's health globally, necessitating a nuanced understanding of their molecular underpinnings for effective personalized treatment strategies. This Special Issue delves into the latest research and innovations in gynecologic oncology, spanning molecular mechanisms, diagnostic modalities, and therapeutic interventions. From elucidating the intricate signaling pathways driving tumorigenesis to exploring novel biomarkers and targeted therapies, these contributions highlight the diverse facets of gynecologic malignancies. Moreover, the emphasis is placed on integrating cutting-edge technologies, such as genomics, proteomics, and immunotherapy, within clinical practice to tailor treatment approaches based on individual patients’ profiles. By fostering an interdisciplinary dialogue and showcasing advancements at the intersection of basic science and clinical care, this Special Issue endeavors to propel the field of gynecologic oncology towards more precise and personalized treatments, ultimately improving patients’ outcomes and quality of life.
Dr. Iason Psilopatis
Dr. Christos Damaskos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- breast cancer
- endometrial cancer
- cervical cancer
- molecular pathway
- epigenetics
- personalized treatment
- targeted therapy
